Skip to main content

Table 2 Intraocular Pressure (IOP) at Baseline and at Various Times after Intravitreal Injection

From: Short-term changes of intraocular pressure and ocular perfusion pressure after intravitreal injection of bevacizumab or ranibizumab

IOP range (mmHg)

No. (%)

Baseline

Immediately

30 min

24 h

1 week

0–9

1 (1.5 %)

 

1 (1.5 %)

2 (3.1 %)

 

10–19

54 (83.1 %)

 

42 (64.6 %)

59 (90.8 %)

59 (90.8 %)

20–29

10 (15.4 %)

5 (7.7 %)

21 (32.3 %)

4 (6.1 %)

6 (9.2 %)

30–39

 

15 (23.1 %)

1 (1.5 %)

  

40–49

 

22 (33.8 %)

   

50–59

 

20 (30.8 %)

   

60–69

 

3 (4.6 %)